Caplin Point Laboratories Limited has informed the Exchange regarding a press release dated May 06, 2024, titled "Press Release on Grant of INVIMA Approval".
Caplin Point Laboratories Limited has informed the Exchange regarding a press release dated May 06, 2024, titled "Press Release on Grant of INVIMA Approval".